Biotron Ltd has released a press release.
Presentation to Investors
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Biotron
- Appointment of International Advisory Board for BIT225
- Presentation at BIO 2019
- Presentation of BIT225-009 hiv-1 phase 2 data
- Response to ASX aware letter
- Biotron Secures $4.7 Million Underwriting Agreement
Later from Biotron
- Biotron Secures $5.1 Million Underwriting Agreement
- Biotron to Test its Compounds Against Coronavirus
- BIT225 restores immune function in hiv-1 infections
- R&D Tax Refund Received
- BIT225 Reverses HIV-Induced Immune Evasion
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron